Wells Fargo & Company Acrivon Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 5,422 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,422
Previous 5,191 4.45%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
N/A
231 Added 4.45%
5,422 $0
Q2 2024

Aug 13, 2024
BUY
N/A
892 Added 20.75%
5,191 $0
Q1 2024

May 10, 2024
BUY
N/A
1,608 Added 59.75%
4,299 $0
Q4 2023

Feb 09, 2024
BUY
N/A
530 Added 24.53%
2,691 $0
Q3 2023

Nov 13, 2023
SELL
N/A
-1,144 Reduced 34.61%
2,161 $0
Q2 2023

Aug 15, 2023
BUY
N/A
1,717 Added 108.12%
3,305 $0
Q1 2023

May 12, 2023
BUY
N/A
1,588 New
1,588 $0

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.2M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email